Third Harmonic Bio Q4 EPS $(0.17) Beats $(0.31) Estimate
Third Harmonic Bio Q4 EPS $(0.17) Beats $(0.31) Estimate
Third Harmonic Bio第四季度每股收益美元（0.17美元）超過預期（0.31美元）
Third Harmonic Bio (NASDAQ:THRD) reported quarterly losses of $(0.17) per share which beat the analyst consensus estimate of $(0.31) by 45.16 percent. This is a 52.78 percent increase over losses of $(0.36) per share from the same period last year.
Third Harmonic Bio（納斯達克股票代碼：THRD）公佈的季度虧損爲每股0.17美元，比分析師普遍預期的0.31美元（0.31美元）高出45.16％。與去年同期的每股虧損（0.36）美元相比，增長了52.78％。
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。